Article

Manual-guided microkeratome provides precise cuts

Lisbon, Portugal - The Moria LSK-one microkeratome provides great accuracy and reproducibility at all cut depths in respect to the intended flap thickness, reported Carlo Lackerbauer, MD, of the University Eye Hospital Munich, Center for Refractive Therapy, Munich, Germany.

Lisbon, Portugal - The Moria LSK-one microkeratome provides great accuracy and reproducibility at all cut depths in respect to the intended flap thickness, reported Carlo Lackerbauer, MD, of the University Eye Hospital Munich, Center for Refractive Therapy, Munich, Germany.

“The microkeratome is an important instrument for lamellar keratoplasty. The accuracy and reproducibility of the corneal flap thickness are important for the refractive outcome,” Dr. Lackerbauer stated.

Dr. Lackerbauer and colleagues used optical low-coherence reflectometry to assess the accuracy and reproducibility of the microkeratome in 100 porcine eyes. The cut depths used were 150, 200, 250, 300, and 350 µm. Three independent readers reviewed the optical-coherence reflectometry results.

The results from all readers showed a high correlation, Dr. Lackerbauer reported Sunday at the European Society of Cataract and Refractive Surgeons meeting. With the 150-µm cut depth the rho was 0.89, p = 0.0002; with the 200-µm cut depth, 0.87, p = 0.0005; with the 250-µm cut depth, 0.93, p = 0.0002; with 300-µm cut depth, 0.94, p = 0.0001, and with the 350-µm cut depth, 0.87; p = 0.0006, Dr. Lackerbauer reported.

“With the 150-µm intended cut, the mean corneal flap thickness was 144  ± 34 µm (p = 0.47); with the 200-µm intended cut, 221 ± 38 µm (p = 0.14); with the 250-µm intended cut, 262 ± 30 µm (p = 0.097); with the 300-µm intended cut, 295 ± 45 µm (p = 0.665), and with the 350-µm intended cut, 374 ± 54 µm (p = 0.07),” he said.

“For lamellar keratoplasty, the Moria LSK-one microkeratome produces corneal flaps with high accuracy and reproducibility for all cut depths with respect to the intended flap thickness,” Dr. Lackerbauer concluded. 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.